Detalhe da pesquisa
1.
SIRT4 in ageing.
Biogerontology
; 24(3): 347-362, 2023 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-37067687
2.
Cognitive Impairment in Phenotypic Leber Hereditary Optic Neuropathy Caused by Mutation in Nuclear Gene NDUFAF5.
J Neuroophthalmol
; 2022 Dec 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-36580434
3.
Topological Electronic Transition Contributing to Improved Thermoelectric Performance in p-Type Mg3Sb2- xBix Solid Solutions.
Adv Mater
; : e2400845, 2024 Apr 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-38651256
4.
The Combination of Trametinib and Ganitumab is Effective in RAS-Mutated PAX-Fusion Negative Rhabdomyosarcoma Models.
Clin Cancer Res
; 29(2): 472-487, 2023 01 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-36322002
5.
Targeting farnesylation as a novel therapeutic approach in HRAS-mutant rhabdomyosarcoma.
Oncogene
; 41(21): 2973-2983, 2022 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-35459782
6.
The membrane-cytoskeleton linker ezrin is necessary for osteosarcoma metastasis.
Nat Med
; 10(2): 182-6, 2004 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-14704791
7.
Rigosertib Induces Mitotic Arrest and Apoptosis in RAS-Mutated Rhabdomyosarcoma and Neuroblastoma.
Mol Cancer Ther
; 20(2): 307-319, 2021 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-33158997
8.
Phosphoprotein pathway mapping: Akt/mammalian target of rapamycin activation is negatively associated with childhood rhabdomyosarcoma survival.
Cancer Res
; 67(7): 3431-40, 2007 Apr 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-17409454
9.
NEMO-binding domain peptides alleviate perihematomal inflammation injury after experimental intracerebral hemorrhage.
Neuroscience
; 409: 43-57, 2019 06 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-31047976
10.
Rapamycin inhibits ezrin-mediated metastatic behavior in a murine model of osteosarcoma.
Cancer Res
; 65(6): 2406-11, 2005 Mar 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-15781656
11.
Correction: Targeting farnesylation as a novel therapeutic approach in HRAS-mutant rhabdomyosarcoma.
Oncogene
; 41(21): 3037, 2022 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-35534540
12.
The Role of PDGFR-ß Activation in Acquired Resistance to IGF-1R Blockade in Preclinical Models of Rhabdomyosarcoma.
Transl Oncol
; 9(6): 540-547, 2016 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-27835791
13.
Levels of PTEN protein modulate Akt phosphorylation on serine 473, but not on threonine 308, in IGF-II-overexpressing rhabdomyosarcomas cells.
Oncogene
; 22(50): 8205-11, 2003 Nov 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-14603261
14.
IGF-1R Inhibition Activates a YES/SFK Bypass Resistance Pathway: Rational Basis for Co-Targeting IGF-1R and Yes/SFK Kinase in Rhabdomyosarcoma.
Neoplasia
; 17(4): 358-66, 2015 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-25925378
15.
Effect of insulin-like growth factor II on protecting myoblast cells against cisplatin-induced apoptosis through p70 S6 kinase pathway.
Neoplasia
; 4(5): 400-8, 2002.
Artigo
em Inglês
| MEDLINE | ID: mdl-12192598
16.
Identification of FoxM1/Bub1b signaling pathway as a required component for growth and survival of rhabdomyosarcoma.
Cancer Res
; 72(22): 5889-99, 2012 Nov 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-23002205
17.
Targeting IGF-1R in the treatment of sarcomas: past, present and future.
Bull Cancer
; 96(7): E52-60, 2009.
Artigo
em Inglês
| MEDLINE | ID: mdl-19617179
18.
Addiction to elevated insulin-like growth factor I receptor and initial modulation of the AKT pathway define the responsiveness of rhabdomyosarcoma to the targeting antibody.
Cancer Res
; 68(19): 8039-48, 2008 Oct 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-18829562
19.
The biology behind mTOR inhibition in sarcoma.
Oncologist
; 12(8): 1007-18, 2007 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-17766661
20.
CCI-779 inhibits rhabdomyosarcoma xenograft growth by an antiangiogenic mechanism linked to the targeting of mTOR/Hif-1alpha/VEGF signaling.
Neoplasia
; 8(5): 394-401, 2006 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-16790088